Analystreport

Teva Pharmaceutical Industries Limited (NYSE: TEVA) was given a new $41.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a "buy" rating on the stock.

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com